A model of angiogenesis in the mouse cornea

Investigative Ophthalmology and Visual Science

Volumn 37, Issue 8, 1996, Pages 1625-1632

  Kenyon, Bärbel M ^a   Voest, Emile E ^a   Chen, Catherine C ^a   Flynn, Evelyn ^a   Folkman, Judah ^a   D'Amato, Robert J ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

angiogenesis; basic fibroblast growth factor; cornea; sucralfate; vascular endothelial growth factor

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; SUCRALFATE; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMBINED IMMUNODEFICIENCY; CONTROLLED STUDY; CORNEA EDEMA; CORNEA LIMBUS; CORNEA NEOVASCULARIZATION; CORNEA STROMA; CORNEA TUMOR; FEMALE; INFLAMMATION; KERATITIS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR GROWTH;

ANIMALS; CORNEA; CORNEAL NEOVASCULARIZATION; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG IMPLANTS; ENDOTHELIAL GROWTH FACTORS; FEMALE; FIBROBLAST GROWTH FACTOR 2; LYMPHOKINES; MALE; MICE; MICE, INBRED C57BL; MICE, NUDE; MICE, SCID; POLYHYDROXYETHYL METHACRYLATE; SUCRALFATE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0029739615     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Ezekowitz RA, Mulliken JB, Folkman J. Interferon alpha-2a therapy for life-threatening hemangiomas of infancy. N Engl J Med. 1992;326:1456-1463.
2. Kusaka M, Sudo K, Fujita T, et al. Potent anti-angiogenic action of AGM-1470: Comparison to the fumagillin parent. Biochem Biophys Res Commun. 1992;174: 1070-1076.
3. D'Amato RJ, Loughnan MS, Flynn E, Folkman J. Thalidomide is an inhibitor of angiogenesis. Proc Natl Acad Sci USA. 1994;91:4082-4085.
4. Auerbach R, Kubai L, Knighton D, Folkman J. A simple procedure for long term cultivation of chicken embryos. Dev Biol. 1974;41:391-394.
5. Crum R, Szabo S, Folkman J. A new class of steroids inhibits angiogenesis in the presence of heparin or a heparin fragment. Science. 1985;230:1375-1378.
6. Miller JW, Stinson WG, Folkman J. Regression of experimental iris neovascularization with systemic alpha-interferon. Ophthalmology. 1993;100:9-14.
7. Passaniti A, Taylor RM, Pili R, et al. Methods in laboratory investigation: A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor. Lab Invest. 1992;67,4:519-528.
8. Klintworth GK. Corneal angiogenesis: A comprehensive critical review. New York: Springer-Verlag; 1991.
9. Alessandri G, Raju K, Gullino PM. Mobilization of capillary endothelium in vitro induced by effectors of angiogenesis in vivo. Cancer Res. 1983;43:1790-1797.
10. Deutsch TA, Hughes WF. Suppressive effects of indomethacin on thermally induced neovascularization of rabbit corneas. Am J Ophthalmol. 1979;87:536-540.
11. Korey M, Peyman GA, Berkowitz R. The effect of hypertonic ointments on corneal alkali burns. Ann Ophthalmol. 1977;9:1383-1387.
12. Mahony JM, Waterbury LD. Drug effects on the neovascularization response to silver nitrate cauterization of the rat cornea. Curr Eye Res. 1985;4:531-535.
13. Gimbrone MA, Cotran RS, Leapman SB, Folkman J. Tumor growth and neovascularization: An experimental model using the rabbit cornea. J Natl Cancer Inst. 1974;52:413-427.
14. Li WW, Grayson G, Folkman J, D'Amore PA. Sustained-release endotoxin: A model for inducing corneal neovascularization. Invest Ophthalmol Vis Sci. 1991;32:2906-2911.
15. Fournier GA, Lutty GA, Watt S, Fenselau A, Patz A. A corneal micropocket assay for angiogenesis in the rat eye. Invest Ophthalmol Vis Sci. 1981;21:351-354.
16. Mutan VR, Auerbach R. Angiogenesis in the mouse cornea. Science. 1979;205:1418-1419.
17. Epstein RJ, Hendricks RL, Stulting RD. Interleukin-2 induces corneal neovascularization in A/J mice. Cornea. 1990;9:318-323.
18. Folkman J, Szabo S, Stovroff M, et al. Duodenal ulcer: Discovery of a new mechanism and development of angiogenic therapy that accelerates healing. Ann Surg. 1991;214,4:414-427.
19. Langer R, Folkman J. Polymers for the sustained release of proteins and other macromolecules. Nature. 1976;263:797-800.
20. Rosenthal RA, Megyesi JF, Henzel WJ, Ferrara N, Folkman J. Conditioned medium from mouse sarcoma180 cells contains vascular endothelial growth factor. Growth Factors. 1990;4:53-59.
21. Esch F, Baird A, Ling N, et al. Primary structure of bovine pituitary basic fibroblast growth factor (FGF) and comparison with the amino terminal sequence of bovine brain acidic FGF. Proc Natl Acad Sci USA. 1985;82:6507-6511.
22. Gospodarowicz D, Ferrara N, Schweigerer L, Neufeld G. Structural characterization and biological functions of fibroblast growth factor. Endocr Rev. 1987;8,2:95-110.
23. Terranova VP, DiFlorio R, Lyall RM, Hie S, Friesel R, Maciag T. Human endothelial cells are chemotactic to endothelial cell growth factor and heparin. J Cell Biol. 1985;101:2330-2334.
24. Montesano R, Vassali JD, Baird A, Guillemin R, Orci L. Basic fibroblast growth factor induces angiogenesis in vitro. Proc Natl Acad Sci USA. 1986;83:7297-7301.
25. Prestrelski SJ, Fox GM, Arakawa T. Binding of heparin to basic fibroblast growth factor induces a conformational change. Arch Biochem Biophys. 1992;293,2:314-319.
26. Polakowski IJ, Lewis MK, Muthukkaruppan VR, Erdman B, Kubai L, Auerbach R, A ribonuclease inhibitor expresses anti-angiogenic properties and leads to reduced tumor growth in mice. Am J Pathol 1993;143: 507-517.
27. Grazyna, Kaminska GM, Niederkorn JY. Spontanous corneal neovascularization in nude mice: Local imbalance between angiogenic and anti-angiogenic factors. Invest Ophthalmol Vis Sci. 1993;34:222-230.
28. Connolly DT, Heuvelman DM, Nelson R, et al. Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J Clin Invest. 1989;84:1470-1478.
29. Ferrara N, Henzel WJ. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun. 1989;162:851-858.